| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/9780470627327.CH15 |
| P50 | author | Vsevolod Katritch | Q28317231 |
| P2093 | author name string | Ruben Abagyan | |
| Kimberly A. Reynolds | |||
| P2860 | cites work | Molecular characterization of the human beta 3-adrenergic receptor | Q24320014 |
| Adenosine receptors as therapeutic targets | Q24632095 | ||
| Flexible ligand docking to multiple receptor conformations: a practical alternative | Q24650066 | ||
| DrugBank: a knowledgebase for drugs, drug actions and drug targets | Q24650300 | ||
| G-protein-coupled receptor heteromers: function and ligand pharmacology | Q24653717 | ||
| The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist | Q24654563 | ||
| High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor | Q24657484 | ||
| Crystal structure of a photoactivated deprotonated intermediate of rhodopsin | Q24671760 | ||
| Structures of the extracellular regions of the group II/III metabotropic glutamate receptors | Q24681315 | ||
| Structure modeling of all identified G protein-coupled receptors in the human genome | Q25256886 | ||
| Crystal structure of rhodopsin: A G protein-coupled receptor | Q27625972 | ||
| Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor | Q27627995 | ||
| Structural views of the ligand-binding cores of a metabotropic glutamate receptor complexed with an antagonist and both glutamate and Gd3+. | Q27638103 | ||
| Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor | Q27647464 | ||
| Crystal Structure of a Thermally Stable Rhodopsin Mutant | Q27647947 | ||
| Crystal structure of the human beta2 adrenergic G-protein-coupled receptor | Q27648868 | ||
| Molecular recognition of parathyroid hormone by its G protein-coupled receptor | Q27650193 | ||
| Crystal structure of squid rhodopsin | Q27650621 | ||
| A Specific Cholesterol Binding Site Is Established by the 2.8 Å Structure of the Human β2-Adrenergic Receptor | Q27650801 | ||
| Crystal structure of the ligand-free G-protein-coupled receptor opsin | Q27650885 | ||
| Structure of a beta1-adrenergic G-protein-coupled receptor | Q27651011 | ||
| Crystal structure of opsin in its G-protein-interacting conformation | Q27652301 | ||
| Assessment of CASP7 structure predictions for template free targets | Q28250552 | ||
| GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function | Q28254935 | ||
| Conformational states and dynamics of rhodopsin in micelles and bilayers | Q37337166 | ||
| G protein-coupled receptors: in silico drug discovery in 3D. | Q37388375 | ||
| Spatial approximation between secretin residue five and the third extracellular loop of its receptor provides new insight into the molecular basis of natural agonist binding | Q37429316 | ||
| Pattern of intra-family hetero-oligomerization involving the G-protein-coupled secretin receptor | Q37430299 | ||
| NMR structure and peptide hormone binding site of the first extracellular domain of a type B1 G protein-coupled receptor | Q37511744 | ||
| Ab initio computational modeling of long loops in G-protein coupled receptors | Q39214506 | ||
| Ab initio computational modeling of loops in G-protein-coupled receptors: lessons from the crystal structure of rhodopsin | Q39215060 | ||
| Comparison of the binding pockets of two chemically unrelated allosteric antagonists of the mGlu5 receptor and identification of crucial residues involved in the inverse agonism of MPEP. | Q40262178 | ||
| Activation of family C G-protein-coupled receptors by the tripeptide glutathione | Q40321361 | ||
| Structural mimicry in class A G protein-coupled receptor rotamer toggle switches: the importance of the F3.36(201)/W6.48(357) interaction in cannabinoid CB1 receptor activation | Q40522976 | ||
| Structure-based identification of binding sites, native ligands and potential inhibitors for G-protein coupled receptors. | Q40594026 | ||
| Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch | Q40712100 | ||
| The forgotten serine. A critical role for Ser-2035.42 in ligand binding to and activation of the beta 2-adrenergic receptor. | Q40858064 | ||
| Crystallographic refinement of ligand complexes | Q40886998 | ||
| Dimerization of the lutropin receptor: insights from computational modeling. | Q41420661 | ||
| Loopholes and missing links in protein modeling | Q41809365 | ||
| Use of an in situ disulfide cross-linking strategy to study the dynamic properties of the cytoplasmic end of transmembrane domain VI of the M3 muscarinic acetylcholine receptor | Q42163985 | ||
| Location of Trp265 in metarhodopsin II: implications for the activation mechanism of the visual receptor rhodopsin | Q42170579 | ||
| Design and synthesis of a series of non-peptide high-affinity human corticotropin-releasing factor1 receptor antagonists | Q42552786 | ||
| Mutational Analysis and Molecular Modeling of the Binding Pocket of the Metabotropic Glutamate 5 Receptor Negative Modulator 2-Methyl-6-(phenylethynyl)-pyridine | Q42609001 | ||
| Differential contribution of two serine residues of wild type and constitutively active β2‐adrenoceptors to the interaction with β2‐selective agonists | Q43173830 | ||
| A new method for ligand docking to flexible receptors by dual alanine scanning and refinement (SCARE). | Q43181588 | ||
| 1-Alkyl-3-amino-5-aryl-1H-[1,2,4]triazoles: novel synthesis via cyclization of N-Acyl-S-methylisothioureas with alkylhydrazines and their potent corticotropin-Releasing factor-1 (CRF1) receptor antagonist activities | Q43807606 | ||
| Virtual screen for ligands of orphan G protein-coupled receptors | Q44096715 | ||
| Comparative analysis of the ligand-binding sites of the metabotropic glutamate receptors mGluR1-mGluR8. | Q44240920 | ||
| Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets? | Q44242205 | ||
| Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approach. | Q44604114 | ||
| Protein flexibility in ligand docking and virtual screening to protein kinases. | Q44786754 | ||
| Synergistic contributions of the functional groups of epinephrine to its affinity and efficacy at the beta2 adrenergic receptor. | Q44854931 | ||
| Design and synthesis of 3-(2-pyridyl)pyrazolo[1,5-a]pyrimidines as potent CRF1 receptor antagonists | Q44958055 | ||
| The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure | Q45029374 | ||
| Successful virtual screening for a submicromolar antagonist of the neurokinin-1 receptor based on a ligand-supported homology model | Q45104890 | ||
| Selective structure-based virtual screening for full and partial agonists of the beta2 adrenergic receptor | Q46445968 | ||
| Predictions of CCR1 chemokine receptor structure and BX 471 antagonist binding followed by experimental validation | Q46533558 | ||
| Substituted tetraazaacenaphthylenes as potent CRF1 receptor antagonists for the treatment of depression and anxiety | Q46537363 | ||
| Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols | Q46655989 | ||
| Calindol, a positive allosteric modulator of the human Ca(2+) receptor, activates an extracellular ligand-binding domain-deleted rhodopsin-like seven-transmembrane structure in the absence of Ca(2+). | Q46681117 | ||
| Mechanisms of inter- and intramolecular communication in GPCRs and G proteins. | Q46706332 | ||
| Allosteric ligands for the corticotropin releasing factor type 1 receptor modulate conformational states involved in receptor activation | Q46779820 | ||
| Determination of key amino acids implicated in the actions of allosteric modulation by 3,3'-difluorobenzaldazine on rat mGlu5 receptors | Q46849536 | ||
| Homology modeling of the serotonin 5-HT1A receptor using automated docking of bioactive compounds with defined geometry | Q46879276 | ||
| Optimization of 3-phenylpyrazolo[1,5-a]pyrimidines as potent corticotropin-releasing factor-1 antagonists with adequate lipophilicity and water solubility | Q47328677 | ||
| A concept for G protein activation by G protein-coupled receptor dimers: the transducin/rhodopsin interface | Q47412010 | ||
| Dark and photoactivated rhodopsin share common binding modes to transducin | Q51622552 | ||
| Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening. | Q51791975 | ||
| Fluorescence resonance energy transfer analysis of secretin docking to its receptor: mapping distances between residues distributed throughout the ligand pharmacophore and distinct receptor residues | Q51794822 | ||
| Molecular approximations between residues 21 and 23 of secretin and its receptor: development of a model for peptide docking with the amino terminus of the secretin receptor | Q51797732 | ||
| TASSER: an automated method for the prediction of protein tertiary structures in CASP6. | Q51963686 | ||
| An automated system for the analysis of G protein-coupled receptor transmembrane binding pockets: alignment, receptor-based pharmacophores, and their application | Q51963840 | ||
| Lessons in molecular recognition: the effects of ligand and protein flexibility on molecular docking accuracy | Q52005770 | ||
| Detailed ab initio prediction of lysozyme–antibody complex with 1.6 Å accuracy | Q52878047 | ||
| Homology model-based virtual screening for GPCR ligands using docking and target-biased scoring | Q53037530 | ||
| Insights into signaling from the β2-adrenergic receptor structure | Q56648606 | ||
| The prediction and orientation of α-helices from sequence alignments: the combined use of environment-dependent substitution tables, Fourier transform methods and helix capping rules | Q56915243 | ||
| Critical Role for the Second Extracellular Loop in the Binding of Both Orthosteric and Allosteric G Protein-coupled Receptor Ligands | Q57838214 | ||
| Rhodopsin dimers in native disc membranes | Q59056014 | ||
| Complexing receptor pharmacology: modulation of family B G protein-coupled receptor function by RAMPs | Q28255872 | ||
| The gene repertoire and the common evolutionary history of glutamate, pheromone (V2R), taste(1) and other related G protein-coupled receptors | Q28277413 | ||
| ICM?A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation | Q29010774 | ||
| The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints | Q29547321 | ||
| Structural diversity of G protein-coupled receptors and significance for drug discovery | Q29616716 | ||
| First principles predictions of the structure and function of g-protein-coupled receptors: validation for bovine rhodopsin. | Q30340985 | ||
| Pocketome via comprehensive identification and classification of ligand binding envelopes. | Q30350345 | ||
| NQ-Flipper: recognition and correction of erroneous asparagine and glutamine side-chain rotamers in protein structures | Q30361425 | ||
| Computational prediction of atomic structures of helical membrane proteins aided by EM maps. | Q30361594 | ||
| Membrane protein structure: prediction versus reality. | Q30362447 | ||
| Activation of G protein-coupled receptors: beyond two-state models and tertiary conformational changes. | Q30364526 | ||
| Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins | Q30421728 | ||
| GPCR 3D homology models for ligand screening: lessons learned from blind predictions of adenosine A2a receptor complex | Q30437388 | ||
| Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes | Q30437514 | ||
| High-affinity CRF1 receptor antagonist NBI-34041: preclinical and clinical data suggest safety and efficacy in attenuating elevated stress response | Q31099140 | ||
| PREDICT modeling and in-silico screening for G-protein coupled receptors. | Q31107931 | ||
| Focused library design in GPCR projects on the example of 5-HT(2c) agonists: comparison of structure-based virtual screening with ligand-based search methods | Q33225159 | ||
| Quaternary structure predictions of transmembrane proteins starting from the monomer: a docking-based approach | Q33249934 | ||
| The 7 TM G-protein-coupled receptor target family | Q33253601 | ||
| GPCR structure-based virtual screening approach for CB2 antagonist search | Q33288322 | ||
| Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs | Q33289718 | ||
| Separating model optimization and model validation in statistical cross-validation as applied to crystallography | Q33294403 | ||
| Synthesis, molecular modeling studies, and preliminary pharmacological characterization of all possible 2-(2'-sulfonocyclopropyl)glycine stereoisomers as conformationally constrained L-homocysteic acid analogs | Q33295330 | ||
| Molecular modeling of the second extracellular loop of G-protein coupled receptors and its implication on structure-based virtual screening | Q33304500 | ||
| Preferential binding of allosteric modulators to active and inactive conformational states of metabotropic glutamate receptors | Q33322203 | ||
| Identifying conformational changes of the beta(2) adrenoceptor that enable accurate prediction of ligand/receptor interactions and screening for GPCR modulators | Q33400428 | ||
| Prediction of structure and function of G protein-coupled receptors | Q34188824 | ||
| [3H]R214127: a novel high-affinity radioligand for the mGlu1 receptor reveals a common binding site shared by multiple allosteric antagonists. | Q34190616 | ||
| The G protein-coupled receptor rhodopsin in the native membrane | Q34432609 | ||
| Allosteric modulators of group I metabotropic glutamate receptors: novel subtype-selective ligands and therapeutic perspectives. | Q34489880 | ||
| The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism | Q34543870 | ||
| Screening the receptorome: an efficient approach for drug discovery and target validation | Q34548337 | ||
| Structure of bovine rhodopsin in a trigonal crystal form. | Q34551940 | ||
| Ligand-selective receptor conformations revisited: the promise and the problem | Q35181787 | ||
| The second extracellular loop of the dopamine D2 receptor lines the binding-site crevice | Q35733326 | ||
| Heavier-than-air flying machines are impossible. | Q35757370 | ||
| Allosteric modulation of G protein-coupled receptors: perspectives and recent developments | Q35902519 | ||
| Crystal packing analysis of Rhodopsin crystals | Q35944832 | ||
| Molecular mechanism of 7TM receptor activation--a global toggle switch model | Q36364704 | ||
| Contributions of intracellular loops 2 and 3 of the lutropin receptor in Gs coupling. | Q36372662 | ||
| Molecular recognition of opioid receptor ligands | Q36439154 | ||
| GLIDA: GPCR--ligand database for chemical genomics drug discovery--database and tools update | Q36454245 | ||
| Homology modeling of G-protein-coupled receptors and implications in drug design | Q36512804 | ||
| GPCR agonists and antagonists in the clinic | Q36514224 | ||
| Optimal bundling of transmembrane helices using sparse distance constraints | Q36526243 | ||
| Allosteric agonists of 7TM receptors: expanding the pharmacological toolbox | Q36556801 | ||
| Inactive and active states and supramolecular organization of GPCRs: insights from computational modeling | Q36606981 | ||
| A functional transmembrane complex: the luteinizing hormone receptor with bound ligand and G protein. | Q36632470 | ||
| G protein coupled receptor structure and activation | Q36692097 | ||
| On the applicability of GPCR homology models to computer-aided drug discovery: a comparison between in silico and crystal structures of the beta2-adrenergic receptor. | Q36744266 | ||
| Metabotropic glutamate receptors as drug targets | Q36822529 | ||
| Molecular modeling and mutagenesis of gap junction channels | Q36831262 | ||
| Predicted 3D structure for the human beta 2 adrenergic receptor and its binding site for agonists and antagonists | Q36852012 | ||
| Conformational complexity of G-protein-coupled receptors | Q36880905 | ||
| Role of lysine187 within the second extracellular loop of the type A cholecystokinin receptor in agonist-induced activation. Use of complementary charge-reversal mutagenesis to define a functionally important interdomain interaction | Q36967031 | ||
| Old and new ways to calculate the affinity of agonists and antagonists interacting with G-protein-coupled monomeric and dimeric receptors: the receptor-dimer cooperativity index. | Q36970776 | ||
| A day in the life of a G protein-coupled receptor: the contribution to function of G protein-coupled receptor dimerization | Q36983708 | ||
| Conformational changes in G-protein-coupled receptors-the quest for functionally selective conformations is open | Q37024485 | ||
| GPCR monomers and oligomers: it takes all kinds | Q37058647 | ||
| The predicted 3D structure of the human D2 dopamine receptor and the binding site and binding affinities for agonists and antagonists. | Q37094875 | ||
| Therapeutic potential of group III metabotropic glutamate receptors | Q37108414 | ||
| Efficient coupling of transducin to monomeric rhodopsin in a phospholipid bilayer | Q37118269 | ||
| Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: A complete structure-activity profile | Q37135506 | ||
| Q-Dock: Low-resolution flexible ligand docking with pocket-specific threading restraints | Q37304442 | ||
| Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008. | Q37309553 | ||
| P921 | main subject | drug discovery | Q1418791 |
| P304 | page(s) | 385-433 | |
| P577 | publication date | 2010-07-15 | |
| P1476 | title | Structure and Modeling of GPCRs: Implications for Drug Discovery |
| Q37045212 | The GPCR Network: a large-scale collaboration to determine human GPCR structure and function | cites work | P2860 |
Search more.